# Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers

> **NCT02777801** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 50 (estimated)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** Entecavir

## Key facts

- **NCT ID:** NCT02777801
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2017-12
- **Final completion:** 2018-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02777801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02777801, "Prophylactic or Preemptive Entecavir in Patients With Gastric Cancer Who Are Inactive Hepatitis B Carriers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02777801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*